-
Je něco špatně v tomto záznamu ?
The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology
DB. Eekers, L. In 't Ven, E. Roelofs, A. Postma, C. Alapetite, NG. Burnet, V. Calugaru, I. Compter, IEM. Coremans, M. Høyer, M. Lambrecht, PW. Nyström, AM. Romero, F. Paulsen, A. Perpar, D. de Ruysscher, L. Renard, B. Timmermann, P. Vitek, DC....
Jazyk angličtina Země Irsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- konsensus MeSH
- kritické orgány * MeSH
- lidé MeSH
- magnetická rezonanční tomografie metody MeSH
- nádory mozku radioterapie MeSH
- plánování radioterapie pomocí počítače metody MeSH
- počítačová rentgenová tomografie metody MeSH
- protonová terapie * MeSH
- radiometrie MeSH
- radioterapie těžkými ionty * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
PURPOSE: To create a digital, online atlas for organs at risk (OAR) delineation in neuro-oncology based on high-quality computed tomography (CT) and magnetic resonance (MR) imaging. METHODS: CT and 3 Tesla (3T) MR images (slice thickness 1 mm with intravenous contrast agent) were obtained from the same patient and subsequently fused. In addition, a 7T MR without intravenous contrast agent was obtained from a healthy volunteer. Based on discussion between experienced radiation oncologists, the clinically relevant organs at risk (OARs) to be included in the atlas for neuro-oncology were determined, excluding typical head and neck OARs previously published. The draft atlas was delineated by a senior radiation oncologist, 2 residents in radiation oncology, and a senior neuro-radiologist incorporating relevant available literature. The proposed atlas was then critically reviewed and discussed by European radiation oncologists until consensus was reached. RESULTS: The online atlas includes one CT-scan at two different window settings and one MR scan (3T) showing the OARs in axial, coronal and sagittal view. This manuscript presents the three-dimensional descriptions of the fifteen consensus OARs for neuro-oncology. Among these is a new OAR relevant for neuro-cognition, the posterior cerebellum (illustrated on 7T MR images). CONCLUSION: In order to decrease inter- and intra-observer variability in delineating OARs relevant for neuro-oncology and thus derive consistent dosimetric data, we propose this atlas to be used in photon and particle therapy. The atlas is available online at www.cancerdata.org and will be updated whenever required.
Clinic for Particle Therapy University Hospital Essen West German Cancer Center Germany
Danish Center for Particle Therapy Aarhus Denmark
Department of Immunology Genetics and Pathology Uppsala University Sweden
Department of Radiation Oncology Eberhard Carls Universität Tübingen Germany
Department of Radiology and Nuclear Medicine MUMC Maastricht The Netherlands
Department of Radiotherapy Oncology Leuven Kanker Instituut UZ Gasthuisberg Belgium
EBG MedAustron GmbH Wiener Neustadt Austria
Erasmus Medical Centre Rotterdam The Netherlands
German Cancer Consortium Heidelberg Germany
German Cancer Consortium partnersite Essen Essen Germany
Haaglanden Medisch Centrum Department of Radiotherapy Leidschendam The Netherlands
Holland Proton Therapy Centre Delft The Netherlands
Institut Curie Radiation Oncology Department Paris and Proton Center Orsay France
Institute Curie Centre de Protonthérapie d'Orsay Orsay France
Institute of Radiooncology OncoRay Helmholtz Zentrum Dresden Rossendorf Dresden Germany
Leiden University Medical Centre Department of Radiotherapy The Netherlands
National Center for Tumor Diseases partnersite Dresden Dresden Germany
OncoRay National Center for Radiation Research in Oncology Dresden Germany
Paul Scherrer Institut med Center for Proton Therapy Switzerland
Proton Therapy Center Czech Prague Czech Republic
Proton Therapy Department South East Netherlands Maastricht The Netherlands
Service de Radiothérapie Oncologique Cliniques universitaires St Luc Brussels Belgium
The Skandion Clinic Uppsala Sweden
University of Cambridge Department of Oncology Addenbrooke's Hospital United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000864
- 003
- CZ-PrNML
- 005
- 20190115123738.0
- 007
- ta
- 008
- 190107s2018 ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.radonc.2017.12.013 $2 doi
- 035 __
- $a (PubMed)29548560
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Eekers, Daniëlle Bp $u Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands; Proton Therapy Department South-East Netherlands (ZON-PTC), Maastricht, The Netherlands. Electronic address: danielle.eekers@maastro.nl.
- 245 14
- $a The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology / $c DB. Eekers, L. In 't Ven, E. Roelofs, A. Postma, C. Alapetite, NG. Burnet, V. Calugaru, I. Compter, IEM. Coremans, M. Høyer, M. Lambrecht, PW. Nyström, AM. Romero, F. Paulsen, A. Perpar, D. de Ruysscher, L. Renard, B. Timmermann, P. Vitek, DC. Weber, HL. van der Weide, GA. Whitfield, R. Wiggenraad, EGC. Troost, . ,
- 520 9_
- $a PURPOSE: To create a digital, online atlas for organs at risk (OAR) delineation in neuro-oncology based on high-quality computed tomography (CT) and magnetic resonance (MR) imaging. METHODS: CT and 3 Tesla (3T) MR images (slice thickness 1 mm with intravenous contrast agent) were obtained from the same patient and subsequently fused. In addition, a 7T MR without intravenous contrast agent was obtained from a healthy volunteer. Based on discussion between experienced radiation oncologists, the clinically relevant organs at risk (OARs) to be included in the atlas for neuro-oncology were determined, excluding typical head and neck OARs previously published. The draft atlas was delineated by a senior radiation oncologist, 2 residents in radiation oncology, and a senior neuro-radiologist incorporating relevant available literature. The proposed atlas was then critically reviewed and discussed by European radiation oncologists until consensus was reached. RESULTS: The online atlas includes one CT-scan at two different window settings and one MR scan (3T) showing the OARs in axial, coronal and sagittal view. This manuscript presents the three-dimensional descriptions of the fifteen consensus OARs for neuro-oncology. Among these is a new OAR relevant for neuro-cognition, the posterior cerebellum (illustrated on 7T MR images). CONCLUSION: In order to decrease inter- and intra-observer variability in delineating OARs relevant for neuro-oncology and thus derive consistent dosimetric data, we propose this atlas to be used in photon and particle therapy. The atlas is available online at www.cancerdata.org and will be updated whenever required.
- 650 _2
- $a nádory mozku $x radioterapie $7 D001932
- 650 _2
- $a konsensus $7 D032921
- 650 12
- $a radioterapie těžkými ionty $7 D063193
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční tomografie $x metody $7 D008279
- 650 12
- $a kritické orgány $7 D058958
- 650 12
- $a protonová terapie $7 D061766
- 650 _2
- $a radiometrie $7 D011874
- 650 _2
- $a plánování radioterapie pomocí počítače $x metody $7 D011880
- 650 _2
- $a počítačová rentgenová tomografie $x metody $7 D014057
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a In 't Ven, Lieke $u Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands.
- 700 1_
- $a Roelofs, Erik $u Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands; The-D Lab: Decision Support for Precision Medicine, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre+, The Netherlands.
- 700 1_
- $a Postma, Alida $u Department of Radiology and Nuclear Medicine MUMC+, Maastricht, The Netherlands.
- 700 1_
- $a Alapetite, Claire $u Institut Curie, Radiation Oncology Department, Paris & Proton Center, Orsay, France.
- 700 1_
- $a Burnet, Neil G $u University of Cambridge Department of Oncology, Addenbrooke's Hospital, United Kingdom.
- 700 1_
- $a Calugaru, Valentin $u Institute Curie, Paris, France; Institute Curie, Centre de Protonthérapie d'Orsay, Orsay, France.
- 700 1_
- $a Compter, Inge $u Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands.
- 700 1_
- $a Coremans, Ida E M $u Leiden University Medical Centre, Department of Radiotherapy, The Netherlands; Holland Proton Therapy Centre, Delft, The Netherlands.
- 700 1_
- $a Høyer, Morton $u Danish Center for Particle Therapy, Aarhus, Denmark.
- 700 1_
- $a Lambrecht, Maarten $u Department of Radiotherapy-Oncology, Leuven Kanker Instituut, UZ Gasthuisberg, Belgium.
- 700 1_
- $a Nyström, Petra Witt $u The Skandion Clinic, Uppsala, Sweden; Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
- 700 1_
- $a Romero, Alejandra Méndez $u Holland Proton Therapy Centre, Delft, The Netherlands; Erasmus Medical Centre, Rotterdam, The Netherlands.
- 700 1_
- $a Paulsen, Frank $u Department of Radiation Oncology, Eberhard-Carls-Universität Tübingen, Germany.
- 700 1_
- $a Perpar, Ana $u EBG MedAustron GmbH, Wiener Neustadt, Austria.
- 700 1_
- $a de Ruysscher, Dirk $u Department of Radiation Oncology (MAASTRO), GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, The Netherlands; Department of Radiotherapy-Oncology, Leuven Kanker Instituut, UZ Gasthuisberg, Belgium.
- 700 1_
- $a Renard, Laurette $u Service de Radiothérapie Oncologique Cliniques universitaires St Luc, Brussels, Belgium.
- 700 1_
- $a Timmermann, Beate $u Clinic for Particle Therapy, University Hospital Essen, West German Cancer Center (WTZ), Germany; West German Proton Therapy Center Essen (WPE), Germany; German Cancer Consortium (DKTK), partnersite Essen, Essen, Germany.
- 700 1_
- $a Vitek, Pavel $u Proton Therapy Center Czech, Prague, Czech Republic.
- 700 1_
- $a Weber, Damien C $u Paul Scherrer Institut med. Center for Proton Therapy, Switzerland.
- 700 1_
- $a van der Weide, Hiske L $u Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.
- 700 1_
- $a Whitfield, Gillian A $u The University of Manchester, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, United Kingdom; The Children's Brain Tumour Research Network, University of Manchester, Royal Manchester Children's Hospital, United Kingdom.
- 700 1_
- $a Wiggenraad, Ruud $u Holland Proton Therapy Centre, Delft, The Netherlands; Haaglanden Medisch Centrum, Department of Radiotherapy, Leidschendam, The Netherlands.
- 700 1_
- $a Troost, Esther G C $u Department of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Dresden, Germany; German Cancer Consortium (DKTK), partnersite Dresden, Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), partnersite Dresden, Dresden, Germany.
- 700 1_
- $a ,
- 773 0_
- $w MED00004049 $t Radiotherapy and oncology journal of the European Society for Therapeutic Radiology and Oncology $x 1879-0887 $g Roč. 128, č. 1 (2018), s. 37-43
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29548560 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190115123948 $b ABA008
- 999 __
- $a ok $b bmc $g 1364854 $s 1038987
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 128 $c 1 $d 37-43 $e 20180313 $i 1879-0887 $m Radiotherapy and oncology $n Radiother Oncol $x MED00004049
- LZP __
- $a Pubmed-20190107
